Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized use and safety of remimazolam in children during perioperative period
ChiCTR2200058718Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children's Medical Center
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remimazolam, sponsored by Guangzhou Women and Children's Medical Center. Primary endpoint: Depth of anesthesia (BIS). Started Apr 2022; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200058718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058718.